Showing results (1911-1920 of 2,726) with videos related to
Sort By:
Pageof 273
Bioanalysis|July 23, 2020
Developing an isotope dilution UHPLC-MS/MS method to quantify linezolid in human plasma: application to therapeutic drug monitoringYanping Guan, Xiaoxia Yu, Ying Wang, et al.Bioanalysis|July 25, 2020
Improving data integrity in regulated bioanalysis: proposal for a generic data transfer process for LC-MS from the European Bioanalysis ForumCecilia Arfvidsson, David Van Bedaf, Susanne Globig, et al.Bioanalysis|July 11, 2020
Clinical application of volumetric absorptive microsampling to the gefapixant development programBrad Roadcap, Azher Hussain, Dan Dreyer, et al.Bioanalysis|August 1, 2020
Overcoming multimeric target interference in a bridging immunogenicity assay with soluble target receptor, target immunodepletion and mild acidic assay pHJihua Chen, Kimberly Kendra, Albert Torri, et al.Bioanalysis|August 1, 2020
Qualified method for the estimation of di-18:1 bis(monoacylglycero)phosphate in urine, a noninvasive biomarker to monitor drug-induced phospholipidosisBokka Venkata Murali, Vishwanath Kurawattimath, Priyadeep Bhutani, et al.Bioanalysis|November 20, 2012
Recommendations on biomarker bioanalytical method validation by GCCRichard Hougton, Dominique Gouty, John Allinson, et al.Bioanalysis|November 20, 2012
Genomic biomarkers for patient selection and stratification: the cancer paradigmSterghios Athanasios MoschosBioanalysis|May 17, 2014
Challenges in selectivity, specificity and quantitation range of ligand-binding assays: case studies using a microfluidics platformTong-Yuan Yang, David J Uhlinger, Stephen A Ayers, et al.Bioanalysis|May 17, 2014
Addressing matrix effects in ligand-binding assays through the use of new reagents and technologyShannon D Chilewski, Johanna R Mora, Carol Gleason, et al.Bioanalysis|May 17, 2014
Evaluating the impact of matrix effects on biomarker assay sensitivityTheingi Thway, Hossein Salimi-MoosaviPageof 273